Treatment of Wound Infection with Enterococcus faecalis in Penicillin-Allergic Patients
For a wound infection with Enterococcus faecalis in a patient with penicillin allergy, vancomycin 15 mg/kg IV every 12 hours is the recommended first-line treatment for 4-6 weeks, with alternatives including daptomycin 6 mg/kg IV daily or linezolid 600 mg PO/IV every 12 hours. 1
Primary Treatment Algorithm
First-Line: Vancomycin
- Vancomycin 15 mg/kg IV every 12 hours is specifically recommended for penicillin-susceptible Enterococcus when penicillin allergy exists 1
- The IDSA guidelines explicitly state "Vancomycin should be used only in case of penicillin allergy" for enterococcal infections 1
- Treatment duration is typically 4-6 weeks for wound infections 1
- Monitor serum vancomycin levels to maintain therapeutic concentrations and avoid nephrotoxicity 1
Alternative Options for Penicillin Allergy
Daptomycin:
- Daptomycin 6 mg/kg IV every 24 hours is an effective alternative 1
- For more severe infections or bacteremia, consider higher doses of 8-12 mg/kg/day 1, 2
- Daptomycin demonstrates bactericidal activity against E. faecalis, including vancomycin-resistant strains 3
- Monitor CPK levels weekly due to risk of myopathy 3
Linezolid:
- Linezolid 600 mg PO or IV every 12 hours provides excellent oral bioavailability 1, 4
- Particularly useful for outpatient transition therapy given oral formulation 4
- E. faecalis maintains high susceptibility rates (>99%) to linezolid 5
- Critical caveat: Monitor for bone marrow suppression and peripheral neuropathy with prolonged use (>2 weeks) 1, 4
Important Clinical Considerations
Species Differentiation Matters
- E. faecalis is generally more susceptible to antibiotics than E. faecium 2
- Approximately 97% of enterococcal infections are caused by E. faecalis 1
- E. faecalis typically remains susceptible to penicillin, ampicillin, and vancomycin 1, 2
Resistance Patterns to Monitor
- Vancomycin resistance in E. faecalis is less common than in E. faecium 6
- If vancomycin resistance is detected, linezolid becomes the preferred agent 1, 2
- Linezolid resistance in E. faecalis remains rare but can develop with prolonged exposure (mean 29.8 days) 5
Combination Therapy Considerations
- Aminoglycosides are NOT routinely recommended for wound infections (reserved for endocarditis or bacteremia) 1
- For severe or complicated wound infections, consider adding gentamicin only if high-level aminoglycoside resistance is absent 1
- Synergistic combinations with daptomycin plus ampicillin or beta-lactams may be considered for severe infections, but penicillin allergy limits this approach 2
Common Pitfalls to Avoid
Do not use cephalosporins as monotherapy - Enterococci are intrinsically resistant to cephalosporins when used alone 2
Avoid fluoroquinolones - These are not recommended for enterococcal wound infections due to poor activity 1
Do not use quinupristin-dalfopristin - This agent is inactive against E. faecalis (only active against E. faecium) 2, 7
Monitor renal function closely with vancomycin - Adjust dosing based on creatinine clearance, particularly in elderly or debilitated patients 1
Reassess if clinical response is suboptimal - Consider susceptibility testing for daptomycin and linezolid if vancomycin fails 1, 6
Duration and Monitoring
- Standard treatment duration: 4-6 weeks for wound infections 1
- Shorter courses (7-14 days) may be appropriate for uncomplicated superficial wound infections 2
- Clinical and laboratory monitoring for efficacy and toxicity should follow IDSA antimicrobial monitoring guidelines 1
- If residual infected tissue remains after debridement, continue pathogen-specific therapy until adequate source control is achieved 1